Variable N High coronary atherosclerotic plaque activity, N = 4211 Low coronary atherosclerotic plaque activity, N = 2831 p-value2
Age 704 65 (58, 71) 61 (56, 67) <0.001
Gender 704 <0.001
    Female 42 (10.0%) 61 (22%)
    Male 379 (90%) 222 (78%)
BMI 704 27.5 (25.2, 30.5) 27.7 (25.5, 31.5) 0.2
SmokingStatus 704 0.056
    Current 103 (24%) 90 (32%)
    Former 134 (32%) 91 (32%)
    Never 184 (44%) 102 (36%)
Hypertension 704 <0.001
    Hypertension 232 (55%) 119 (42%)
    No hypertension 189 (45%) 164 (58%)
HighCholesterol 699 0.6
    High cholesterol 236 (56%) 162 (58%)
    Normal cholesterol 185 (44%) 116 (42%)
DiabetesMellitus 704 0.13
    Diabetes Mellitus 78 (19%) 40 (14%)
    No Diabetes Mellitus 343 (81%) 243 (86%)
IschaemicHeartDisease 704 0.004
    Coronary artery disease 98 (23%) 41 (14%)
    No coronary artery disease 323 (77%) 242 (86%)
MyocardialInfarction 704 0.3
    Myocardial infarction 66 (16%) 36 (13%)
    No previous myocardial infarction 355 (84%) 247 (87%)
PreviousPCI 704 0.007
    No previous PCI 349 (83%) 255 (90%)
    Previous PCI 72 (17%) 28 (9.9%)
PreviousCABG 704 0.9
    No previous CABG 402 (95%) 271 (96%)
    Previous CABG 19 (4.5%) 12 (4.2%)
PeripheralVascularDisease 704 0.11
    No peripheral vascular disease 412 (98%) 271 (96%)
    Peripheral vascular disease 9 (2.1%) 12 (4.2%)
StrokeTIA 704 0.2
    Cerebrovascular disease 23 (5.5%) 10 (3.5%)
    No cerebrovascualr disease 398 (95%) 273 (96%)
ECGFinding 704 0.6
    NSTEMI 147 (35%) 94 (33%)
    STEMI 274 (65%) 189 (67%)
SeverityCAD_4C 704 0.6
    1 Vessel 16 (3.8%) 12 (4.2%)
    2 Vessels 224 (53%) 163 (58%)
    3 Vessels 149 (35%) 90 (32%)
    Left main stem disease 32 (7.6%) 18 (6.4%)
Aspirin 673
    Aspirin use 405 (100%) 268 (100%)
P2Y12Antagonist 688
    P2Y12 receptor antagonist use 409 (100%) 279 (100%)
Anticoagulant 42
    Anticoagulant use 25 (100%) 17 (100%)
Statin 653
    Statin use 393 (100%) 260 (100%)
ACEInhibitorOrARB 623
    ACE inhibitor or ARB use 373 (100%) 250 (100%)
BetaBlocker 573
    β-Adrenergic receptor antagonist use 340 (100%) 233 (100%)
CalciumChannelBlocker 64
    Calcium-channel antagonist use 45 (100%) 19 (100%)
Nitrate 384
    Nitrate use 226 (100%) 158 (100%)
OtherAntiAnginal 22
    Other antianginal therapy use 14 (100%) 8 (100%)
Mineralocorticoid 42
    Mineralocorticoid receptor antagonist use 21 (100%) 21 (100%)
OtherDiuretic 54
    Other diuretic therapy use 32 (100%) 22 (100%)
1 Median (IQR); n (%)
2 Wilcoxon rank sum test; Pearson’s Chi-squared test